Advertisement

Topics

CRISPR Therapeutics Plans to Treat First Patients for Beta Thalassemia in Europe

20:00 EDT 15 Apr 2018 | BioSpace

The plan is to treat patients with beta thalassemia, a blood disorder that decreases the production of hemoglobin, the iron-containing protein in red blood cells that carries oxygen.

Original Article: CRISPR Therapeutics Plans to Treat First Patients for Beta Thalassemia in Europe

NEXT ARTICLE

More From BioPortfolio on "CRISPR Therapeutics Plans to Treat First Patients for Beta Thalassemia in Europe"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...